The NKG2D-Fc system also allows us to deliver other immune-modulating or anti-cancer molecules (i.e., other than IL-2) to the tumor loci with the added benefit of reduced toxicity because of its specific targeting capabilities. The gene discussed is IL2; the disease is cancer.